Promote your products
Click Here To Find Out How
FDA Registered
At Body Balance System, we're committed to providing red light therapy systems that meet the highest safety and quality standards. Our systems are FDA registered, reflecting our dedication to compliance with federal regulations and demonstrating our commitment to excellence. This registration provides your wellness business with the confidence that you are offering clients a trusted and reliable treatment option.
FDA Registration Number #3010627475
NRTL Certified
Beyond FDA registration, we go the extra mile to ensure the safety and performance of our products. Our system, the OvationULT bed, undergoes rigorous testing by Nationally Recognized Testing Laboratories (NRTLs) like SGS – a global leader in product safety certification. These independent labs evaluate our systems for EMF, radiation, electrical safety, and FCC compliance. This meticulous third-party verification guarantees our reported outputs are accurate and validated, giving you and your clients peace of mind and the most effective red light therapy experience possible.
NRTL Certification Number: SGSNA/25/SUW 00264
Proudly Manufactured in the USA. Prices unaffected by tariffs.
Financing Options to Grow Your Business
Financing options are subject to approval and available for those who qualify.
Discover the Power of Red Light Therapy
Learn how red light therapy can enhance your wellness practice and elevate client experiences.
What Our Clients Are Saying
-
I've used Body Balance System for 5 years. One of my clients with a recurring brain tumor saw the spot disappear after regular foot baths—nothing else changed. The doctors were amazed!
-
After Rocky Mountain Spotted Fever, my joint pain vanished after a few sessions. Sinus issues are gone too. Perfect for professional use—reliable, easy to clean, and great service.
-
Chronic knee pain made work impossible until I tried Body Balance System. One foot bath eased my pain, letting me move again. Highly recommend!
Why Choose Us
At Body Balance System, we are dedicated to empowering wellness practices with innovative solutions. Our commitment to quality, performance, and customer satisfaction sets us apart in the industry, ensuring that you receive the best products and support for your business.
Our Priority
FDA Registered Products
Our systems meet rigorous safety and efficacy standards, giving you peace of mind when offering treatments to your clients.
Handcrafted in the USA
Each of our products is meticulously crafted in Las Vegas, ensuring quality and attention to detail that mass-produced alternatives can't match.
Innovative Technology
We continuously invest in research and development to provide cutting-edge solutions that enhance the wellness experience for your clients.
Exceptional Customer Support
Our dedicated team is here to support you every step of the way, from product selection to training and beyond.
Satisfied Clients
Years in Business
Wellness Partners
Innovative Products
Innovative Wellness Solutions for Your Business
At Body Balance System, we specialize in advanced solutions designed to elevate wellness experiences and deliver exceptional results.
-
Red Light TherapyOur advanced red light therapy systems use state-of-the-art technology to provide non-invasive treatments that enhance wellness. With high-quality diodes for optimal performance and ergonomic designs for client comfort, these systems ensure maximum light penetration and a relaxing experience. -
Detox SolutionsOur detox solutions offer a holistic approach to cleansing and rejuvenating the body. These solutions are designed to help individuals eliminate toxins and achieve optimal levels of balance and health. Experience the benefits of detoxification and take a proactive step towards enhancing your wellness journey.
Featured Press
Red Light Therapy Locator
Explore our network of wellness practices that offer our advanced red light therapy products. Find a location near you where to experience our innovative solutions.
Stay Informed with Our Blog
-
May, 2026Red Light Therapy Session Pricing: How Commercial Operators Maximize Revenue Per HourPricing red light therapy is the single biggest leverage point in a commercial program. The same bed at the same utilization can generate $42,000 a year or $144,000 a year, depending on how the pricing structure is built. The difference is not session price. It is the blend across walk-ins, packages, and memberships, combined with throughput discipline at the room level.
This article gives commercial operators a concrete framework for pricing red light therapy. It covers the three pricing layers, the math for revenue per hour at different utilization scenarios, and the operational moves that protect throughput. It also addresses the questions that come up most often during a discovery call: how do I price against the spa down the street, how do I avoid discounting, and how do I think about membership margins.
The numbers below assume a single OvationULT commercial bed at the standard spec point: 65 milliwatts per square centimeter at the contact surface, 10 to 20 minute session length, 2 clients per hour throughput on a calibrated 15 minute session plus transition. Local market conditions vary. Operators should adjust the framework to their own client base, geography, and existing service mix.
What is the throughput ceiling for a commercial red light therapy bed?
Throughput is the operational ceiling on revenue. No pricing model can exceed it.
A commercial red light therapy bed running 15 minute sessions, paired with a 15 minute transition window, seamlessly delivers 2 clients per operating hour at full utilization. This 15 minute buffer provides a relaxed experience for the client to dress and exit, while naturally accommodating the room sanitation and the device's recommended cooldown cycle between sessions. While some operators might try to squeeze in 3 clients per hour with 10 minute sessions and rushed turnovers, the 2 client per hour model is the most sustainable, compliant, and realistic planning ceiling for steady state operations.
At 2 clients per hour, the daily ceiling for an 8 hour operating day is 16 clients. The annual ceiling at 300 operating days is 4,800 sessions.
These are ceilings, not expectations. Few commercial beds run at 100 percent of throughput. Realistic year one utilization is 30 to 50 percent of ceiling. Year two and beyond, well-run programs reach 60 to 80 percent.
Once an operator understands the throughput ceiling, the pricing question becomes simple. What is the revenue per session, and how do I maximize the blended number across the realistic utilization range.
What are the three pricing layers in a commercial red light therapy program?
A mature commercial red light therapy program runs three pricing layers in parallel. Each one serves a different client and a different revenue purpose.
Layer one is per session pricing. A walk-in client pays a single session fee, typically $40 to $75 for 15 minutes. Per session pricing is the highest revenue per session but the lowest utilization driver. It exists to capture casual interest and convert first-time clients.
Layer two is multi-session packages. A 10 session package at $400, or a 20 session package at $700, brings the per session price down to $35 to $40. Package pricing trades headline rate for committed utilization. Most clients who buy a 10 pack use it within 90 days. Packages drive return visits, and return visits drive lifetime value.
Layer three is membership pricing. A monthly membership at $99 to $199 includes a defined number of sessions, often 4 to 8 per month, sometimes unlimited. Membership pricing has the lowest revenue per session, often $15 to $30, but the highest retention and the strongest predictable cash flow. A membership client who shows up weekly is a high lifetime value client.
Pricing layer
Revenue per session
Client commitment
Utilization driver
Per session
$40 to $75
None
Low
10 session package
$35 to $50
90 day usage window
Moderate
Unlimited membership
$15 to $30
Monthly recurring
High
The pricing question is not which layer to choose. It is how to balance the blend so that revenue per hour stays high while utilization grows.
How do you calculate revenue per hour for a commercial red light therapy bed?
Revenue per hour is the metric that ties pricing to the throughput ceiling. It is calculated as follows.
Revenue per hour equals sessions per hour multiplied by blended revenue per session.
At the throughput ceiling of 2 sessions per hour and a blended revenue per session of $50, revenue per hour is $100. At a blended revenue per session of $35, revenue per hour drops to $70. The headline session price is less important than the blended number across all three layers.
A worked example at three blended pricing scenarios:
Scenario
Sessions per hour
Blended revenue per session
Revenue per hour
Daily revenue (8 hours, 50% utilization)
Premium blend
2
$55
$110
$440
Balanced blend
2
$40
$80
$320
Membership heavy
2
$25
$50
$200
The premium blend assumes a higher proportion of walk-in and package clients with fewer membership clients. The balanced blend assumes the typical mature program with a healthy mix across all three layers. The membership heavy blend describes a program that has heavily discounted access to drive volume.
At 300 operating days a year and 50 percent utilization, the annual revenue across these three scenarios is $66,000, $48,000, and $30,000 respectively. The pricing structure, not the device, drives that outcome.
What is the right blended revenue per session for most operators?
Most commercial operators land at a blended revenue per session of $35 to $50, with a healthy mix across the three pricing layers.
The mix that produces a $40 to $45 blended number typically looks like this. Roughly 20 percent of sessions are per session walk-ins at $50 to $65. Roughly 50 percent are package sessions at $35 to $40. Roughly 30 percent are membership sessions at $20 to $25. The blend lifts revenue per hour while still producing the predictable membership cash flow that supports lease, staffing, and equipment.
Programs that price below this blend usually have a discounting problem. They started with aggressive introductory offers, ran promotions too long, and trained their client base to wait for the next sale. Recovering from that pattern takes 6 to 12 months of disciplined repricing.
Programs that price above this blend usually serve a higher-end client base, often in a luxury hospitality or medical aesthetics environment. These programs charge $75 to $100 per session, sell smaller and more expensive packages, and run a low-volume, high-margin model. The math works at lower utilization because revenue per session is materially higher.
There is no single right number. The right number is the one that fits the local market, the existing service menu, and the operator's revenue targets.
How should operators think about membership margins?
Membership pricing is the most common source of confusion in commercial red light therapy programs. The two questions are always the same. How many sessions should the membership include, and what is the margin if the client uses every one.
The answer depends on the cost structure. Variable cost per red light session is small. Electricity runs $1 to $3 per session at U.S. commercial rates. Sanitation supplies run under $1. There is no consumable, no provider hour, and no licensing fee. The marginal cost of one additional session, in a bed already running, is under $5.
This is why unlimited memberships work for red light therapy in a way they do not work for facials or laser treatments. The bed runs whether the client is in it or not. Adding one more session per week to a membership client's usage costs the operator a few dollars in electricity. The retention value of that weekly visit is worth far more than the marginal cost.
The right way to think about membership pricing is retention margin, not session margin. A $149 a month membership that includes weekly red light visits, attached to an existing facial membership, lifts renewal rates. The lifted renewal rate, applied across the membership base, produces more revenue than the per-session math would suggest.
For a deeper breakdown of red light therapy economics inside a medspa, see our companion post on How to Add Red Light Therapy to Your Medspa.
How do you avoid discounting and protect price discipline?
Discounting is the single fastest way to compress revenue per session. The pattern is consistent across operator interviews. A new program launches with an introductory offer. The offer extends. New clients learn that prices are flexible. Repricing back to standard rates produces churn. The program never recovers full margin.
The discipline that prevents this pattern has three parts.
Part one: cap introductory offers at a fixed window. A free first session or a 50 percent discount on the first package is fine for the first 90 days of a launch. After 90 days, the offer ends. New clients see standard pricing. Returning clients who missed the offer learn that promotions are time-bound, not permanent.
Part two: avoid Groupon and daily deal sites. These channels train clients to expect 70 to 80 percent discounts as the default price. Acquiring a client through Groupon and then asking them to pay full price for a follow up package produces high churn and bad reviews.
Part three: make package and membership the default sale, not the per session price. Front desk training matters here. The standard offer at the consultation should be a 10 pack or a membership, not a single session. The per session price exists for the walk-in who is genuinely testing, not as the primary product.
How do you reprice a program that has compressed margins?
Repricing a program that has trained itself into discount territory takes patience.
The first step is documenting the current blend. Run a 30 day report from the booking system. Pull average revenue per session across all clients, all three pricing layers, and all promotional categories. The blended number is usually 20 to 40 percent below where it should be, and the gap shows where the discounting concentrated.
The second step is repricing the membership and package SKUs. Existing membership and package clients keep their current rates for the duration of their commitment. New clients see the new rates from the repricing date. Communicate the change clearly. Repricing without communication produces churn.
The third step is removing the standing discounts. A 20 percent off code that has been on the website for 18 months is not a promotion. It is the price. Removing it lifts revenue per session immediately on new clients while protecting current clients on their existing terms.
The fourth step is rebuilding the front desk script. The standard offer becomes the package or membership. The per session price is offered only on direct request. This shifts the average sale up without aggressive selling.
Most programs see a 15 to 30 percent lift in revenue per session within 90 days of a disciplined repricing.
How does the OvationULT support a high revenue per hour pricing model?
The OvationULT is built for commercial throughput. Three specifications matter for revenue per hour.
First, irradiance at 65 milliwatts per square centimeter at the contact surface supports calibrated 12 to 20 minute session protocols within published dose response evidence. Lower irradiance devices require longer sessions to deliver comparable doses, which compresses throughput and revenue per hour.
Second, the bed runs on a 120 volt standard outlet. Many competing commercial beds require 240 volt service or dedicated electrical work that adds installation cost and limits room placement flexibility. The 120 volt standard simplifies room conversion and keeps the bed runnable in standard medspa, gym, and recovery center electrical layouts.
Third, the 5 year white glove warranty eliminates the maintenance variability that compresses payback math on lower-tier devices. White glove service means parts, labor, and on-call response over the full warranty window.
Body Balance System is FDA registered under registration number 3010627475, with the OvationULT listed under the ILY product code. Trust installations include the Bellagio, Aria, Four Seasons, Fairmont, and Canyon Ranch.
For the full economic case, see The Complete Guide to Commercial Red Light Therapy.
FAQ
What is a typical price for a single red light therapy session in 2026?
Per session pricing in commercial settings runs $40 to $75 for a 12 to 20 minute full body session. Luxury hospitality and medical aesthetics environments can run $75 to $100 per session.
What is the typical price for a 10 session red light therapy package?
A 10 session package typically runs $300 to $500, bringing the per session rate to $30 to $50. Package pricing is the most common commercial model because it balances revenue per session with utilization.
Should I offer unlimited red light therapy memberships?
Unlimited memberships work well for red light therapy because variable cost per session is low. The pricing decision is about retention margin, not session margin. A typical structure is $99 to $199 per month for unlimited or capped weekly access.
How many clients per hour can one commercial red light therapy bed serve?
Two clients per operating hour is the realistic steady state ceiling at 15 minute sessions plus 15 minute transitions. Three per hour is possible in short bursts but not sustainable across a full operating day.
How do I avoid discounting my red light therapy pricing?
Cap introductory offers at 90 days, avoid Groupon and daily deal sites, and make packages or memberships the default sale at the front desk rather than per session pricing.
What is a realistic year one revenue for a commercial red light therapy bed?
At moderate utilization (50 percent of throughput ceiling) and a $40 blended revenue per session, a single bed produces roughly $48,000 in year one. Year two and beyond, well-run programs reach $84,000 to $120,000 in annual revenue.
Internal Links
How to Add Red Light Therapy to Your Medspa: Revenue, ROI, and Implementation
The Complete Guide to Commercial Red Light Therapy
What FDA Registered Actually Means in Red Light Therapy
How Does Red Light Therapy Work?
External Citations
American Med Spa Association: 2025 Industry Report - Industry benchmarks for medspa pricing and membership economics.
International Health, Racquet and Sportsclub Association (IHRSA) industry data - Membership economics and retention research applicable to recurring service models.
FDA Establishment Registration and Device Listing Database - Public verification of manufacturer FDA registration status.
FDA CDRH Product Classification Database - Official source for ILY product code and indications.
U.S. Energy Information Administration: Commercial Electricity Rates - Reference for variable cost calculations on commercial equipment.
-
May, 2026Red Light Therapy Research: 5 Peer-Reviewed Studies Every Operator Should KnowMost commercial red light therapy buyers ask the same question during evaluation: where is the science. The answer is that photobiomodulation, the technical name for red and near-infrared light therapy at therapeutic wavelengths, is one of the most published areas in modern wellness research. PubMed indexes more than 7,000 peer-reviewed studies on the topic, with new papers appearing every week.
For a commercial operator, the volume is the problem, not the solution. Most published research is animal model or in vitro work that does not translate directly to commercial bed protocols. Some human trials are small and underpowered. A few are well-designed randomized controlled trials. Knowing which is which is the difference between marketing copy that survives FDA scrutiny and marketing copy that does not.
This article highlights five studies that every commercial operator should know by name. Each one is peer-reviewed, citable, and represents a distinct piece of the evidence base: mechanism, dose response, wavelength selection, application, and the limits of current research. We summarize each study's design, primary finding, and the responsible way to reference it in client conversations and marketing copy. We also note what each study does not prove, because that distinction matters for FDA registered manufacturers and the operators who buy from them.
Why does the published research base matter for a commercial operator?
The research base matters for three operational reasons.
First, it sets the boundary for client conversations. An operator who cites peer-reviewed evidence accurately builds trust. An operator who overstates findings creates exposure. The FTC has issued warning letters to wellness businesses that claim therapeutic benefits beyond their device's regulatory scope (FTC Health Products Compliance Guidance). Knowing what the evidence supports, and what it does not, is the cleanest defense.
Second, it informs equipment selection. Studies use specific wavelengths, irradiance levels, and dose ranges. Equipment that operates outside those parameters delivers something different from what the studies tested. A bed marketed at 850 nanometers behaves differently from one marketed at 660 nanometers, and the published evidence for each wavelength is not interchangeable.
Third, it stabilizes pricing conversations. A client asking why a 15 minute session costs $50 deserves more than a marketing claim. Citing a specific dose response study and explaining why session length is calibrated to that evidence shifts the conversation from "trust me" to "here is the evidence." That shift matters for membership renewals.
The five studies below are starting points, not the entire literature. An operator who reads these five and understands them is better prepared than 95 percent of the market.
Study 1: What did Karu's mechanism research establish about cytochrome c oxidase?
Citation: Karu, T. (1999). Primary and secondary mechanisms of action of visible to near-IR radiation on cells. Journal of Photochemistry and Photobiology B: Biology, 49(1), 1 to 17.
Study type: Review paper synthesizing mechanism research
What it established: Tiina Karu's foundational work identified cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain, as a primary photoacceptor for red and near-infrared light. The paper proposed that photon absorption by cytochrome c oxidase increases ATP production and modulates downstream cellular signaling. This mechanism is now the most widely cited explanation for the cellular effects of photobiomodulation (Journal of Photochemistry and Photobiology B).
What it does not prove: The Karu mechanism is well-supported in cell culture and in vitro work. It does not prove any specific clinical outcome at the whole-body level. The path from "ATP production increases at the cellular level" to "this client's joint pain improves" requires additional clinical evidence for each application.
How an operator should reference it: "Published mechanism research suggests that red and near-infrared wavelengths interact with cytochrome c oxidase to support cellular energy production." This is accurate, attributed to research, and stays within ILY scope.
Study 2: What did the Huang dose response review reveal about the biphasic curve?
Citation: Huang, Y. Y., Chen, A. C., Carroll, J. D., & Hamblin, M. R. (2009). Biphasic dose response in low level light therapy. Dose-Response, 7(4), 358 to 383.
Study type: Review paper analyzing dose response patterns across the published literature
What it established: The Huang paper documented what photobiomodulation researchers call the biphasic dose response. Across multiple published studies, biological response increased with light dose up to a peak, then decreased as dose continued to increase. More light was not better past the inflection point. The paper established that effective photobiomodulation requires a calibrated dose, not a maximum dose (Dose-Response journal).
What it does not prove: The biphasic curve is well-documented in mechanism studies and selected clinical trials. The exact peak dose for each application, tissue type, and individual is not established. Operators should treat published dose ranges as informed starting points, not precise prescriptions.
Why it matters for commercial protocols: Session length, irradiance, and frequency all factor into total dose. A high irradiance bed at 65 milliwatts per square centimeter delivers a calibrated dose in a 12 to 20 minute session. A low irradiance device may require a longer session to deliver the same dose, and may still fall short of the documented effective range.
Study 3: What did the Hamblin near-infrared review establish about tissue penetration?
Citation: Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337 to 361.
Study type: Review paper covering mechanism, wavelength selection, and inflammation research
What it established: Hamblin synthesized published evidence on tissue penetration depth for red and near-infrared wavelengths. Red light at 630 to 670 nanometers is absorbed primarily by skin and superficial tissue. Near-infrared light at 810 to 850 nanometers penetrates several millimeters deeper into muscle and connective tissue. The paper also reviewed published evidence on photobiomodulation effects on inflammatory markers in cell culture and animal models (AIMS Biophysics).
What it does not prove: Penetration depth is reasonably well-established in tissue optics. The paper does not prove that deeper penetration always produces better clinical outcomes. The right wavelength depends on the target tissue and the application, not a single "deeper is better" rule.
How an operator should reference it: "Published research on photobiomodulation indicates that 630 to 670 nanometer wavelengths interact primarily with superficial tissue, while 810 to 850 nanometer wavelengths penetrate to deeper muscle and connective tissue." Accurate, sourced, and useful for explaining why a commercial bed combines both wavelength ranges.
Study 4: What did the Ferraresi muscle recovery research show?
Citation: Ferraresi, C., Huang, Y. Y., & Hamblin, M. R. (2016). Photobiomodulation in human muscle tissue: an advantage in sports performance? Journal of Biophotonics, 9(11 to 12), 1273 to 1299.
Study type: Review paper synthesizing muscle and athletic performance research
What it established: The Ferraresi paper reviewed dozens of published studies on photobiomodulation applied to human muscle tissue before, during, and after exercise. The synthesized findings included evidence for reduced post-exercise inflammation markers, faster recovery of muscle force, and reduced delayed onset muscle soreness in selected studies. The paper organized the evidence by study design, dose, and application timing (Journal of Biophotonics).
What it does not prove: Athletic recovery applications have a growing evidence base, but the studies vary in quality. Some are small open label studies. Others are well-designed randomized controlled trials. The Ferraresi review acknowledges this variation and does not claim that photobiomodulation is universally effective for athletic recovery.
Why it matters for commercial operators: This is the citation that supports recovery and athletic positioning, when used responsibly. An operator can reference the published evidence on muscle recovery without claiming that the OvationULT, or any specific commercial bed, treats injuries or accelerates healing. The distinction between "published research suggests" and "this device treats" is the line between compliant and non-compliant marketing.
Study 5: What did the Cochrane review conclude about the limits of current evidence?
Citation: Brosseau, L., Robinson, V., Wells, G., et al. (2005). Low level laser therapy (Classes I, II and III) for treating osteoarthritis. Cochrane Database of Systematic Reviews, (2), CD002046.
Study type: Cochrane systematic review
What it established: Cochrane reviews are considered the highest tier of evidence synthesis in medical research. The 2005 review on low level laser therapy for osteoarthritis examined published randomized controlled trials and concluded that the evidence at the time was mixed. Some studies showed benefit, others did not, and methodological quality varied. The review called for higher-quality randomized controlled trials before drawing definitive conclusions (Cochrane Library).
What it does not prove: The Cochrane review does not say photobiomodulation does not work. It says, accurately, that the evidence base is incomplete and inconsistent. Subsequent reviews and trials have continued to add evidence on both sides.
Why every operator should know this study: This is the citation that prevents overclaiming. An operator who can quote a Cochrane review and explain that the evidence base is still developing builds more credibility than one who cherry picks favorable studies. The Cochrane review is the antidote to marketing copy that overstates the science.
[INFOGRAPHIC: The 5 Foundational Photobiomodulation Studies Every Operator Should Know]
How do these five studies compare side by side?
Study
Year
Type
Primary contribution
What it does not prove
Karu, mechanism
1999
Review
Cytochrome c oxidase as photoacceptor
Specific clinical outcomes
Huang, dose response
2009
Review
Biphasic dose response curve
Exact optimal dose per application
Hamblin, wavelengths
2017
Review
Tissue penetration by wavelength
That deeper is always better
Ferraresi, muscle
2016
Review
Athletic recovery evidence
Universal athletic efficacy
Cochrane, osteoarthritis
2005
Systematic review
Limits of current evidence
That photobiomodulation does not work
How should an operator reference research without making product claims?
This is the practical question that determines whether marketing copy is compliant or exposed.
The clean structure follows three rules.
Rule one: attribute findings to research, not to the device. "Published research suggests that photobiomodulation may support cellular energy production" is compliant. "Our red light therapy bed boosts cellular energy" is not. The first describes peer-reviewed evidence. The second is a product claim outside ILY scope.
Rule two: cite specific studies with full URLs. A reference to "studies show" or "research suggests" without a citation is weak both rhetorically and legally. A specific citation with author, year, journal, and URL is verifiable, defensible, and demonstrates earned authority.
Rule three: state the limit of the evidence. When a study supports a finding in muscle tissue, do not extend the claim to whole-body benefits. When a study is small, say it is small. The operator who acknowledges limits is more credible than the one who hides them.
For a deeper breakdown of FDA registered scope and the difference between research and product claims, see our companion post on What FDA Registered Actually Means in Red Light Therapy.
What does this body of evidence mean for Body Balance System and the OvationULT?
Body Balance System is FDA registered under registration number 3010627475, with the OvationULT listed under the ILY product code for infrared lamp heating. Within ILY scope, the device is described accurately for topical heating, temporary relief of minor muscle and joint pain and stiffness, temporary relief of minor arthritis pain, relaxation of muscle spasm, and temporary increase of local circulation.
Beyond ILY scope, the OvationULT is not marketed as a treatment for specific diseases or conditions. The published research above is referenced as research, not as evidence that any one device treats anything. This is the operating discipline an FDA registered manufacturer is required to maintain, and the same discipline operators should expect from any manufacturer they evaluate.
The OvationULT delivers 65 milliwatts per square centimeter at the contact surface across both red and near-infrared wavelength bands, with full body coverage and 12 to 20 minute session protocols calibrated to published dose response evidence. The 5 year white glove warranty supports commercial deployment in medspas, gyms, recovery centers, and hospitality spas at properties including the Bellagio, Aria, Four Seasons, Fairmont, and Canyon Ranch.
FAQ
How many peer-reviewed studies exist on red light therapy?
PubMed currently indexes more than 7,000 papers on photobiomodulation, the technical term for red and near-infrared light therapy at therapeutic wavelengths. The volume continues to grow, with new studies appearing every week.
Are the published studies all human trials?
No. The literature includes cell culture work, animal model studies, and human clinical trials. The strongest evidence for any specific application is randomized controlled trials in humans, but those represent a minority of the total literature.
Can an operator cite published research in marketing without FDA exposure?
Yes, when done correctly. Attributing findings to the research, citing specific studies with URLs, and not extending those findings into product claims about the operator's specific device keeps the citation within compliant scope.
What is the difference between a single study and a systematic review?
A single study reports one experiment with one population. A systematic review evaluates many studies on the same question and synthesizes the combined evidence. Cochrane reviews and other systematic reviews are considered higher tier evidence than individual studies.
Should an operator quote studies during client consultations?
Selectively. Citing one or two foundational studies builds credibility. Reciting a literature review during a consultation overwhelms the client. The best practice is to know the studies well enough to answer questions when they come up, not to lead with them.
Internal Links
How Does Red Light Therapy Work? A Manufacturer's Guide to Photobiomodulation
What FDA Registered Actually Means in Red Light Therapy
The Complete Guide to Commercial Red Light Therapy
How to Add Red Light Therapy to Your Medspa
External Citations
Huang, Y. Y. et al. (2009). Biphasic dose response in low level light therapy. Dose-Response
Ferraresi, C. et al. (2016). Photobiomodulation in human muscle tissue. Journal of Biophotonics
-
May, 2026How to Add Red Light Therapy to Your Medspa: Revenue, ROI, and ImplementationAdding red light therapy to a medspa generates $8,000–$18,000/month at moderate utilization, with equipment costs recovered in 4–8 months. The service requires approximately 100 sq ft of floor space, a standard 3-prong outlet, and 10–15 minute sessions. A commercial-grade full-body bed running 2 clients per hour produces predictable recurring revenue that complements injections, facials, and body contouring. This post covers the revenue math, equipment selection, compliance framework, and the membership model that converts single sessions into monthly recurring income.
Why Are Medspas Adding Red Light Therapy in 2026?
Practices that add high-throughput, low-touch services alongside core injection and device revenue achieve better revenue per square foot, higher visit frequency, and stronger client retention.
Client demand for non-invasive wellness is measurable: medspa clients want services with no downtime, no needles, and no recovery period. A botox client visits 3–4 times per year. A red light therapy membership client visits 2–4 times per week. That compounding effect on visit frequency and cross-service conversion is material. In most markets, standalone RLT studios exist but few medspas offer clinical-grade full-body beds, which means early movers occupy a distinct competitive position.
What Are the Revenue Projections for a Single Red Light Therapy Bed?
A commercial full-body bed running 6 operational hours per day at modest utilization generates $8,000–$18,000 per month. Equipment payback runs 4–8 months.
Two variables drive outcomes: session price and sessions per day. A commercial bed designed for 10–15 minute sessions with a 30-second cleanup protocol can complete 2 clients per hour, or 12 sessions over a 6-hour operating day.
Revenue Projection Matrix
Sessions/Day
Utilization
$50/session
$75/session
$100/session
$125/session
$150/session
4
33%
$6,000
$9,000
$12,000
$15,000
$18,000
6
50%
$9,000
$13,500
$18,000
$22,500
$27,000
8
67%
$12,000
$18,000
$24,000
$30,000
$36,000
10
83%
$15,000
$22,500
$30,000
$37,500
$45,000
12
100%
$18,000
$27,000
$36,000
$45,000
$54,000
Assumes 25 operating days per month. These are gross revenue projections; operating costs, consumables, and staffing are separate.
ROI Timeline
Equipment cost: $55,000 (OvationULT Zero Gravity Bed)
Conservative case: $75/session x 6 sessions/day x 25 days = $11,250/month gross. Payback at 4.9 months.
Moderate case: $100/session x 8 sessions/day x 25 days = $20,000/month gross. Payback at 2.75 months.
Annual revenue range (year 1, moderate utilization, no membership): $96,000–$216,000. At a medspa where existing staff handle client intake and the bed operates with minimal supervision, marginal cost per session is low: primarily linens, cleaning solution, and a fraction of front-desk time.
What Should You Look for When Evaluating Commercial Red Light Therapy Equipment?
The difference between a consumer-grade product and a purpose-built commercial device determines whether you run 2 clients per hour or wait 20 minutes between sessions for the unit to cool down.
Commercial Equipment Evaluation Framework
Specification
What to Ask
Why It Matters
Irradiance at body surface
mW/cm² at actual client-to-device distance
Determines therapeutic dose; unmeasured claims are unverifiable
Diode count and wavelengths
Total diodes, nm for each array
Coverage and treatment completeness
Electrical requirements
Standard outlet or dedicated circuit?
Standard outlet = no electrician cost
Session throughput
Duty cycle, cooling time between sessions
Determines actual revenue capacity
Cleanup time
How long between clients?
Whether "2 clients/hour" is achievable
Warranty
Years, coverage, who performs service
White-glove vs. ship-back warranty = very different downtime exposure
FDA registration
Device listing number, product code, classification
Verifiable at fda.gov
NRTL certification
UL, CSA, SGS, Intertek, etc.
Electrical safety for commercial deployment
The OvationULT Zero Gravity Bed against this framework: 65 mW/cm² irradiance at body surface (measured at 2–3" client proximity), 28,443 total diodes (22,755 x 635 nm red + 5,688 x 850 nm NIR), standard 3-prong outlet, 30-second cleanup protocol, 175 lbs, FDA-registered Class II device (Registration #3010627475, Device Listing #877966, Product Code ILY, 21 CFR 890.5500), SGS North America NRTL certified, 5-year white-glove warranty, manufactured in Las Vegas, NV.
How Does the Membership Model Change the Revenue Math?
Per-session revenue is a floor, not a ceiling. A client purchasing a $299/month membership for 8 sessions generates $3,588/year in guaranteed recurring revenue, compared to $1,560 if they visit quarterly as a single-session client.
Membership vs. Single-Session Revenue: 12-Month Comparison
Client Type
Sessions/Month
Price/Session
Monthly Revenue
Annual Revenue
Single-session (quarterly)
1.3 avg
$100
$130
$1,560
10-pack buyer (3x/year)
2.5 avg
$80
$200
$2,400
Basic membership (2x/week)
8 sessions
$37
$299
$3,588
Premium membership (4x/week)
16 sessions
$25
$399
$4,788
Session-equivalent pricing reflects the cost per session embedded in each tier. Membership economics favor the operator on both revenue and retention.
Membership Pricing Architecture
Entry-level ($149–$199/month): 4–8 sessions/month. Minimal friction for clients already spending $300–$500/month on other services.
Active ($249–$299/month): 12–16 sessions/month. These clients drive referral traffic and carry the highest lifetime value.
Add-on bundle: RLT membership paired with one facial or discounted injectables. Locks in multi-service revenue while making the math compelling for the client.
For room setup details, staff training protocols, and a full marketing playbook, see our complete operator's guide.
What Compliance Obligations Apply to Red Light Therapy in a Medspa?
When marketing red light therapy, stay within general wellness claims. For FDA-registered Class II devices with an ILY product code, cleared indications include temporary relief of minor muscle and joint pain, relaxation of muscle spasm, and temporary increase of local circulation. Do not claim RLT treats, cures, or prevents named medical conditions, and avoids implying specific therapeutic outcomes in before/after photography. Have your medical director or legal counsel review consent documentation and marketing language against FTC guidelines and your state's medspa regulations. In most states, FDA-registered Class II PBM beds do not require elevated physician involvement compared to other non-ablative devices, but state-by-state variation exists.
Frequently Asked Questions
How much space does a commercial red light therapy bed require?
Plan for 100–120 sq ft. The bed footprint is approximately 80–85 inches long by 36–40 inches wide. You need clearance on all sides for client entry and exit, plus space for a small side table. Standard 8-foot ceilings and existing HVAC are sufficient.
Can red light therapy be combined with other medspa services?
Yes. RLT is commonly positioned before or after facials, and in the 24–48 hours following injectable appointments as a recovery-supportive service. There are no known adverse interactions with standard medspa services at therapeutic intensities. Train staff to discuss combinations at every applicable appointment.
What is the typical utilization rate in the first 90 days?
Most operators see 30–50% utilization in the first 90 days as they build awareness and a membership base. With consistent marketing to existing clients and front-desk prompting at every applicable appointment, 60–75% utilization by month 4–6 is achievable. At 50% utilization and $100/session, a single bed generates $15,000/month gross.
Do you need a medical director specifically for red light therapy?
This varies by state. FDA-registered Class II commercial PBM beds are generally categorized as general wellness devices, not medical procedures. Review your state's medspa statute and your existing medical director agreement. Most states do not require an elevated level of physician involvement for RLT compared to other non-ablative devices.
How do I explain red light therapy to a client who has never tried it?
Keep it direct: "It's a 10–15 minute full-body session in a bed that emits specific wavelengths of red and near-infrared light. The light interacts with your cells at the mitochondrial level, signaling them to produce more energy. Most clients use it for recovery, relaxation, and overall wellness. No heat, no downtime, you're out the door immediately after." Avoid clinical language that implies disease treatment.
Citations
Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017;4(3):337-361. doi: 10.3934/biophy.2017.3.337. PMID: 28748217. https://pubmed.ncbi.nlm.nih.gov/28748217/
Ferraresi C, Huang YY, Hamblin MR. Photobiomodulation in human muscle tissue: an advantage in sports performance? J Biophotonics. 2016;9(11-12):1273-1299. doi: 10.1002/jbio.201600176. PMID: 27874264. https://pubmed.ncbi.nlm.nih.gov/27874264/
Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41-52. PMID: 24049929. https://pmc.ncbi.nlm.nih.gov/articles/PMC4126803/
FDA Device Registration #3010627475. Device Listing #877966. Product Code ILY. Classification: 21 CFR 890.5500. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm
Body Balance System has manufactured commercial red light therapy equipment in Las Vegas, NV for 13 years. The OvationULT Zero Gravity Bed is an FDA-registered Class II device (Registration #3010627475, Device Listing #877966, Product Code ILY, 21 CFR 890.5500), certified by SGS North America (NRTL), and installed in properties including the Four Seasons Beverly Wilshire, Four Seasons Hong Kong, Bellagio, and Aria.
-
April, 2026What "FDA Registered" Actually Means in Red Light Therapy (And Why It Matters for Your Business)"FDA registered," "FDA cleared," and "FDA approved" mean three distinct things under federal law. The red light therapy industry routinely conflates all three. For operators buying $50,000+ commercial equipment, the distinction is not academic. It determines what claims you can legally make to clients, what liability you carry, and whether the device meets commercial safety standards. This post covers what each term means, what product code ILY actually permits, and how to verify a manufacturer's status in under 10 minutes using public FDA databases.
Why Does FDA Terminology Matter When You're Buying $50K+ Equipment?
If a manufacturer misrepresents their regulatory status, you inherit the risk. As the operator serving clients with the equipment, you are the last line of consumer protection. The FDA does not pre-approve every marketing claim a device manufacturer makes. The compliance burden lands on you: when a client asks "is this FDA approved?" or when a state health inspector shows up, the operator is responsible.
There is also a commercial dimension. Operators in wellness, chiropractic, medspa, and luxury hospitality increasingly face due diligence questions from insurers, credentialing bodies, and institutional clients. A major health system or professional sports organization asking about your device does not want to hear "it's registered" and accept that at face value. They want to know the classification, the permitted uses, and whether independent safety certification exists.
The vocabulary matters. Here is what it actually means.
What Does "FDA Registered" Mean?
"FDA registered" means a manufacturer has completed establishment registration with the FDA under 21 CFR Part 807 and has listed their device in the FDA's device listing database. That is the complete definition. The FDA knows the establishment exists, knows what it claims to manufacture, and has assigned it a registration number.
What it does not mean:
-
The FDA has reviewed the device
-
The FDA has tested the device
-
The FDA has evaluated the device's safety or efficacy claims
-
The FDA has approved or endorsed the device for any use
Under 21 CFR § 807.37(c), the FDA states explicitly: "validation of registration and the assignment of a device listing number in itself does not establish that the holder of the registration is legally qualified to deal in such devices and does not represent a determination by the Food and Drug Administration as to the status of any device."
Practical implication: FDA registration is the floor, not the ceiling. Its absence is a significant red flag. Its presence tells you nothing about product quality, clinical efficacy, or the accuracy of marketing claims.
What Does "FDA Cleared" Mean?
Clearance applies to Class II devices that have completed the 510(k) premarket notification process. Under 510(k), a manufacturer must demonstrate their device is substantially equivalent to a legally marketed predicate device. The FDA reviews the submission and issues a clearance decision. A cleared device is cleared for the specific intended uses stated in the 510(k), not as a blanket endorsement.
How this applies to red light therapy: Under product code ILY and 21 CFR § 890.5500, infrared therapeutic heating lamp devices are classified as Class II but are exempt from premarket notification requirements. This means a properly classified ILY device does not need 510(k) clearance before reaching market, provided it stays within the permitted indications. The ILY exemption is not a loophole; it is the regulatory framework. A device claiming to do more than ILY permits would need separate 510(k) clearance for those additional claims.
What Does "FDA Approved" Mean?
"FDA Approved" refers specifically to the Premarket Approval (PMA) pathway for Class III devices: the highest-risk category. PMA requires clinical trials demonstrating safety and effectiveness, full manufacturing quality system review, and formal FDA approval before the device reaches market.
No commercial red light therapy bed holds FDA approval. Zero. The PMA pathway is not the appropriate regulatory framework for ILY-classified infrared lamp devices. Any manufacturer claiming their red light therapy bed is "FDA approved" is making a statement that is factually false under federal law. 21 CFR § 807.39 prohibits misbranding a device by misrepresenting its regulatory status. As an operator who repeats that claim to clients, you carry shared exposure.
What Is Product Code ILY, and What Claims Does It Actually Permit?
Under 21 CFR § 890.5500, the FDA classifies infrared lamps as:
"A device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating."
Field
Detail
Product Code
ILY
Device Name
Lamp, Infrared, Therapeutic Heating
Regulation
21 CFR 890.5500
Device Class
II (special controls)
Submission Type
510(k) Exempt
Review Panel
Physical Medicine
The permitted claims under ILY are specific and limited:
-
Temporary relief of minor muscle and joint pain and stiffness
-
Temporary relief of minor arthritis pain
-
Relaxation of muscle spasm
-
Temporary increase of local circulation where heat is indicated
Those four claims are what a red light therapy device operating under ILY classification is permitted to make without additional regulatory action. Any device marketed for weight loss, anti-aging, immune support, hormone balance, cognitive enhancement, or treatment of specific disease conditions is either operating under a different regulatory clearance (which you should ask to see) or making claims the FDA has not reviewed.
Note the word "temporary" throughout. It is not a technicality. It reflects the FDA's characterization of the device's intended effect.
What Claims Should You Be Skeptical Of?
Published research on photobiomodulation is credible and growing. A 2016 review by de Freitas and Hamblin in the IEEE Journal of Selected Topics in Quantum Electronics and a 2017 review by Hamblin in AIMS Biophysics document mechanistic pathways and potential applications far beyond ILY scope. That research is real. But "research suggests" and "this device is cleared to treat" are not the same statement.
If a manufacturer makes claims in any of the following categories, ask to see the 510(k) clearance number that covers them:
Brain health / cognitive function: Outside ILY scope. Transcranial PBM devices have separate regulatory pathways.
Immune system modulation: Outside ILY scope. Disease prevention claims trigger different regulatory requirements.
Hormone optimization: Outside ILY scope. Endocrine system claims require clinical substantiation and regulatory review.
Weight loss / fat reduction: Outside ILY scope unless the device holds separate clearance.
Chronic disease treatment: Outside ILY scope. Any claim involving "treatment" of a named condition requires specific clearance.
Skin tightening / collagen induction: May have separate clearance, but not covered by ILY.
If you purchase equipment marketed with out-of-scope claims and repeat those claims to clients, a regulatory inquiry puts limited defense in pointing at the manufacturer. The equipment was in your facility. The claims came from your business.
How Do You Verify a Manufacturer's FDA Registration?
This takes under 10 minutes and should happen before you sign any purchase agreement. Use public FDA databases:
Step 1: Get the FEI Number. Ask the manufacturer for their FDA Establishment Identifier (FEI). Any registered manufacturer should provide it immediately. If they cannot, that is a red flag.
Step 2: Search the establishment database. Go to https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm. Enter the company name or FEI number. A registered manufacturer will appear with establishment address and registration status.
Step 3: Check the device listing. From the establishment record, confirm the device name, product code (ILY for a red light therapy bed), regulation number (890.5500), and device class (Class II).
Step 4: Verify the product code. Go to https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm to confirm what ILY covers.
Step 5: Cross-reference claims. Review the manufacturer's website. Any claim not covered by the four ILY-permitted indications should prompt one question: "What regulatory clearance covers this?"
BBS verification: Body Balance System's FDA registration number is #3010627475, device listing #877966, Product Code ILY, Class II. Verified at accessdata.fda.gov.
What About NRTL Certification?
FDA registration governs intended use claims. NRTL certification governs electrical safety. Both matter for commercial operators; they address different risks.
Under OSHA 29 CFR 1910.303, electrical equipment used in workplaces must be listed or labeled by a Nationally Recognized Testing Laboratory (NRTL), an organization OSHA has recognized for electrical safety testing. Common NRTLs include UL (Underwriters Laboratories), ETL (Intertek), SGS, and CSA.
For a commercial red light therapy bed drawing power in a business setting, NRTL certification is not optional. A device without it creates OSHA exposure for the operator, separate from and independent of any FDA regulatory questions. The combination that matters: an FDA-registered device with a confirmed ILY listing, plus NRTL certification, gives you the complete compliance baseline for commercial operation. BBS OvationULT carries SGS North America NRTL certification.
FDA Registered vs. FDA Cleared vs. FDA Approved: Side-by-Side
Term
What It Means
What's Required
What It Does NOT Mean
Common Misuse in RLT
FDA Registered
Manufacturer has registered establishment and listed device with FDA
Establishment registration (21 CFR 807.20) + device listing; annual renewal
FDA review, testing, approval, or endorsement
Presented as equivalent to clearance or approval
FDA Cleared
FDA reviewed 510(k) and found device substantially equivalent to predicate
Premarket Notification (510(k)) with performance data; active FDA review
Clinical trials; proof of superiority; FDA approval
Conflated with "FDA approved"; also misapplied to 510(k)-exempt devices
FDA Approved
FDA reviewed PMA application with clinical trial data and granted approval
Clinical trials, full manufacturing review, extensive evidence dossier; PMA pathway
Applies to Class III only; not applicable to ILY devices
"FDA approved red light therapy" (factually false for any RLT bed)
510(k) Exempt
Device type established enough that FDA exempted it from premarket notification
Establishment registration + device listing within permitted product code indications
That anything goes; claims must still stay within ILY scope
Sometimes misrepresented as a lesser status; it is a distinct regulatory category
Can any company call their device "FDA registered"?
Registration requires completing establishment registration with the FDA and listing the device. It is not automatic. However, it does not require FDA review or product testing. The presence of registration is meaningful (it is required for legal commercial distribution); it is not a substitute for understanding what the device is actually classified to do.
Does FDA registration mean the device is safe?
Not directly. Registration means the manufacturer has notified the FDA of their existence and their device. Electrical safety is assessed through NRTL certification (UL, ETL, SGS), a separate evaluation performed by an independent testing laboratory. For a complete safety baseline, you need both FDA establishment registration and NRTL certification.
What is the difference between ILY and OLY product codes?
ILY covers "Lamp, Infrared, Therapeutic Heating" under 21 CFR 890.5500: the product code for red light therapy and infrared lamp devices. OLY covers "Lamp, Ultraviolet, Therapeutic": a completely different device type with different applications, different risks, and different regulatory requirements. A red light therapy bed should be listed under ILY.
Should I ask for a manufacturer's FEI number before buying?
Yes, and verify it before signing any purchase agreement. The FEI number is the anchor for searching the public FDA database at accessdata.fda.gov. A manufacturer who is genuinely registered will provide it without hesitation. One who cannot either has not completed registration or does not know their own regulatory status. Both are concerning for a $50,000+ commercial purchase.
Where can I learn more about evaluating commercial red light therapy equipment?
Our complete operator's guide covers the full evaluation framework covering regulatory status, hardware specifications, and operational compliance for commercial red light therapy operators.
Citations
21 CFR § 890.5500: Infrared lamp. https://www.law.cornell.edu/cfr/text/21/890.5500
FDA Product Classification Database: Product Code ILY. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=ILY
21 CFR Part 807: Establishment Registration and Device Listing. https://www.law.cornell.edu/cfr/text/21/807.20
FDA Establishment Registration and Device Listing Database. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/textsearch.cfm
FDA: Class I and Class II Device Exemptions. https://www.fda.gov/medical-devices/classify-your-medical-device/class-i-and-class-ii-device-exemptions
FDA: Who Must Register, List and Pay the Fee. https://www.fda.gov/medical-devices/device-registration-and-listing/who-must-register-list-and-pay-fee
OSHA 29 CFR 1910.303: Electrical Standards. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.303
de Freitas LF, Hamblin MR. "Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy." IEEE J Sel Top Quantum Electron. 2016;22(3):7000417. PMID: 28070154. https://pubmed.ncbi.nlm.nih.gov/28070154/
Hamblin MR. "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophys. 2017;4(3):337–361. PMID: 28748217. https://pubmed.ncbi.nlm.nih.gov/28748217/
K142340: FDA 510(k) Clearance for Infrared Therapy System, ILY classification example. https://www.accessdata.fda.gov/cdrh_docs/pdf14/K142340.pdf
Body Balance System | Las Vegas, NV | FDA Registration #3010627475 | Device Listing #877966 | Product Code ILY | Class II | 21 CFR 890.5500 | SGS North America NRTL Certified | Made in USA
-
- Choosing a selection results in a full page refresh.
- Opens in a new window.